Authors/Disclosures
|
Henry Osso-Rivera, MD
(Texas Children'S Hospital-West Campus)
|
No disclosure on file |
|
Temitayo Oyegbile-Chidi, MD, PhD, FAAN
(University of California Davis)
|
Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Spectrum/The Transmitter. The institution of Dr. Oyegbile-Chidi has received research support from NIH. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Mary Kay Koenig, MD
(University of Texas Health Science Center-Houston)
|
Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth BioTherapeutics. Dr. Koenig has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Abliva AB. The institution of Dr. Koenig has received research support from EryDel SPA. The institution of Dr. Koenig has received research support from PTC Therapeutics. The institution of Dr. Koenig has received research support from Noema Pharmaceuticals. The institution of Dr. Koenig has received research support from Marinus Pharmaceuticals. The institution of Dr. Koenig has received research support from Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Nflexion Therapeutics. The institution of Dr. Koenig has received research support from Stealth BioTherapeutics. The institution of Dr. Koenig has received research support from Astellas Pharmaceuticals. The institution of Dr. Koenig has received research support from Reneo Pharmaceuticals. |
|
|
No disclosure on file |
|
William D. Gaillard, MD
(Children'S National Hospital)
|
The institution of Dr. Gaillard has received research support from all federal or foundation grants, NINDS, NIDCD, NICHD, NSF ,PERF. |